The Effect of Sufentanil Administration on Remifentanil-Based Anaesthesia during Laparoscopic Gynaecological Surgery: A Double-Blind Randomized Controlled Trial

Table 3

Postoperative pain based on visual analogue scale (VAS) and postoperative nausea and vomiting (PONV).

	C group (𝑁=39)	S group (𝑁=39)	𝑃
𝑇1
VAS	48±9	21±11	0.000
PONV incidence	6	1	0.108
PONV scale	0.2±0.6	0.0±0.2	0.048
Analgesic	13	0	0.000
Antiemetic	3	0	0.240
𝑇1-𝑇2
VAS	50±8	27±10	0.000
PONV incidence	4	5	1.000
PONV scale	0.2±0.5	0.2±0.6	0.712
Analgesic	7	0	0.012
Antiemetic	2	2	1.000
𝑇2-𝑇3
VAS	35±8	19±8	0.000
PONV incidence	15	12	0.475
PONV scale	0.6±1.1	0.6±0.9	0.719
Analgesic	3	0	0.240
Antiemetic	3	2	1.000
Rhodes index	3.4±5.3	2.9±5.4	0.613
𝑇3-𝑇4
VAS	24±8	24±6	0.743
PONV incidence	3	2	1.000
PONV scale	0.1±0.4	0.1±0.2	0.629
Analgesic	0	0	—
Antiemetic	1	0	1.000
Rhodes index	0.5±2.0	0.2±0.9	0.471
𝑇4-𝑇5
VAS	16±6	15±4	0.606
PONV incidence	2	0	0.494
PONV scale	0.1±0.4	0.0±0.0	0.155
Analgesic	0	0	—
Antiemetic	0	0	—
Rhodes index	0.3±1.2	0.00±0.00	0.155

Data was expressed as mean ± standard deviation or number of patients.
C group: normal saline group; S group: sufentanil group; 𝑇1: on arrival to the postanaesthetic care unit (PACU); 𝑇2: at 30 min after PACU arrival; 𝑇3: at 24 h after PACU discharge; 𝑇4: at 48 h after PACU discharge; 𝑇5: at 72 h after PACU discharge; PONV assessed on a three- point ordinal scale (0 = none, 1 = nausea, 2 = retching, and 3 = vomiting).